Risk factors and outcome of early recurrence after resection of small hepatocellular carcinomas

被引:48
作者
Kaibori, Masaki [1 ]
Ishizaki, Morihiko [1 ]
Saito, Takamichi [1 ]
Matsui, Kosuke [1 ]
Kwon, A-Hon [1 ]
Kamiyama, Yasuo [1 ]
机构
[1] Kansai Med Univ, Dept Surg, Hirakata Hosp, Osaka 5731191, Japan
关键词
Small hepatocellular carcinoma; Hepatic resection; Early recurrence; Risk factor; PERCUTANEOUS ETHANOL INJECTION; VIRUS-RELATED CIRRHOSIS; LOCAL ABLATIVE THERAPY; LONG-TERM PROGNOSIS; INTRAHEPATIC RECURRENCE; CURATIVE RESECTION; ADJUVANT CHEMOTHERAPY; LIVER; HEPATECTOMY; SURGERY;
D O I
10.1016/j.amjsurg.2008.07.051
中图分类号
R61 [外科手术学];
学科分类号
100210 [外科学];
摘要
BACKGROUND: This study aimed to clarify risk factors for early recurrence and examine the subsequent Outcome in patients undergoing potentially R0 resection of small hepatocellular carcinomas (HCCs) (<= 52 cm in greatest dimension). METHODS: Eighty-nine patients were divided into 2 groups as follows: 26 patients suffering from recurrence within 2 years of surgery (early recurrence group) and 63 patients who were disease-free for at least 2 years (disease-free 2Y group). RESULTS: Only 7 of 63 patients (11%) from the group that was disease-free for at least 2 years died during the 5-year period after surgery, whereas 13 of 26 patients (50%) from the early recurrence group died. Multivariate analysis showed that the preoperative maximum removal rate of technetium-99m-diethylenetriamine pentaacetic acid-galactosyl human serum albumin and microscopic vascular invasion were independent predictors of the early recurrence of small HCC. CONCLUSIONS: Early recurrence of small HCC is the leading cause of death within 5 years after R0 resection. The preoperative hepatic functional reserve influences early recurrence, even in patients with small tumors. (C) 2009 Published by Elsevier Inc.
引用
收藏
页码:39 / 45
页数:7
相关论文
共 50 条
[1]
Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan [J].
Arii, S ;
Yamaoka, Y ;
Futagawa, S ;
Inoue, K ;
Kobayashi, K ;
Kojiro, M ;
Makuuchi, M ;
Nakamura, Y ;
Okita, K ;
Yamada, R .
HEPATOLOGY, 2000, 32 (06) :1224-1229
[2]
Epidemiology of primary liver cancer [J].
Bosch, FX ;
Ribes, J ;
Borràs, J .
SEMINARS IN LIVER DISEASE, 1999, 19 (03) :271-285
[3]
Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results [J].
Buscarini, L ;
Buscarini, E ;
Di Stasi, M ;
Vallisa, D ;
Quaretti, P ;
Rocca, A .
EUROPEAN RADIOLOGY, 2001, 11 (06) :914-921
[4]
CASTELLS A, 1993, HEPATOLOGY, V18, P1121
[5]
A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma [J].
Chen, MS ;
Li, JQ ;
Zheng, Y ;
Guo, RP ;
Liang, HH ;
Zhang, YQ ;
Lin, XJ ;
Lau, WY .
ANNALS OF SURGERY, 2006, 243 (03) :321-328
[6]
Couinaud C., 1957, FOIE ETUDES ANATOMIQ, P400
[7]
Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death [J].
Degos, F ;
Christidis, C ;
Ganne-Carrie, N ;
Farmachidi, JP ;
Degott, C ;
Guettier, C ;
Trinchet, JC ;
Beaugrand, M ;
Chevret, S .
GUT, 2000, 47 (01) :131-136
[8]
Rising incidence of hepatocellular carcinoma in the United States [J].
El-Serag, HB ;
Mason, AC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (10) :745-750
[9]
Liver transplantation for hepatocellular carcinoma [J].
Hemming, AW ;
Cattral, MS ;
Reed, AI ;
Van der Werf, WJ ;
Greig, PD ;
Howard, RJ .
ANNALS OF SURGERY, 2001, 233 (05) :652-658
[10]
The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States [J].
Hu, KQ ;
Tong, MJ .
HEPATOLOGY, 1999, 29 (04) :1311-1316